[HTML][HTML] Biomimetic nanoplasmonic sensor for rapid evaluation of neutralizing SARS-CoV-2 monoclonal antibodies as antiviral therapy

R Batool, M Soler, F Colavita, L Fabeni… - Biosensors and …, 2023 - Elsevier
Monoclonal antibody (mAb) therapy is one of the most promising immunotherapies that have
shown the potential to prevent or neutralize the effects of COVID-19 in patients at very early …

[HTML][HTML] Nanoplasmonic multiplex biosensing for COVID-19 vaccines

R Funari, H Fukuyama, AQ Shen - Biosensors and Bioelectronics, 2022 - Elsevier
The ongoing emergence of severe acute respiratory syndrome caused by the new
coronavirus (SARS-CoV-2) variants requires swift actions in identifying specific antigens and …

Selective detection and ultrasensitive quantification of SARS-CoV-2 IgG antibodies in clinical plasma samples using epitope-modified nanoplasmonic biosensing …

AN Masterson, R Sardar - ACS applied materials & interfaces, 2022 - ACS Publications
Monitoring the human immune response by assaying (detection and quantification) the
antibody level against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is …

Impedimetric nanobiosensor for the detection of SARS-CoV-2 antigens and antibodies

DI Sandoval Bojórquez, Z Janićijević… - ACS …, 2023 - ACS Publications
Detection of antigens and antibodies (Abs) is of great importance in determining the
infection and immunity status of the population, as they are key parameters guiding the …

Sensitivity-enhanced nanoplasmonic biosensor using direct immobilization of two engineered nanobodies for SARS-CoV-2 spike receptor-binding domain detection

Z Ma, Z Sun, X Lv, H Chen, Y Geng, Z Geng - Sensors and Actuators B …, 2023 - Elsevier
Sensitive, rapid, and easy-to-implement biosensors are critical in responding to highly
contagious and fast-spreading severe acute respiratory syndrome coronavirus (SARS-CoV …

Novel nanostructure-coupled biosensor platform for one-step high-throughput quantification of serum neutralizing antibody after COVID-19 vaccination

L Huang, Y Li, C Luo, Y Chen, N Touil… - Biosensors and …, 2022 - Elsevier
COVID-19 vaccination efficacy depends on serum levels of the neutralizing antibodies (NAs)
specific to the receptor-binding domain of the severe acute respiratory syndrome …

Multiplexed COVID-19 antibody quantification from human sera using label-free nanoplasmonic biosensors

W Adi, D Biswas, MA Shelef, F Yesilkoy - Biomedical Optics Express, 2022 - opg.optica.org
Serological assays that can reveal immune status against COVID-19 play a critical role in
informing individual and public healthcare decisions. Currently, antibody tests are performed …

Label-free plasmonic biosensor for rapid, quantitative, and highly sensitive COVID-19 serology: Implementation and clinical validation

O Calvo-Lozano, M Sierra, M Soler… - Analytical …, 2021 - ACS Publications
Serological tests are essential for the control and management of COVID-19 pandemic
(diagnostics and surveillance, and epidemiological and immunity studies). We introduce a …

Multiplexed and high-throughput label-free detection of RNA/spike protein/IgG/IgM biomarkers of SARS-CoV-2 infection utilizing nanoplasmonic biosensors

AN Masterson, BB Muhoberac, A Gopinadhan… - Analytical …, 2021 - ACS Publications
To tackle the COVID-19 outbreak, which is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), there is an unmet need for highly accurate diagnostic tests at …

[HTML][HTML] Nanoplasmonic biosensor for rapid detection of multiple viral variants in human serum

N Bhalla, AF Payam, A Morelli, PK Sharma… - Sensors and Actuators B …, 2022 - Elsevier
As viruses constantly change due to mutation, variants are expected to emerge demanding
development of sensors capable of detecting multiple variants using one single sensor …